AA
Ascentage Pharma Group International
AAPG · NASDAQ
$15.06 -2.02% (-$0.31)
1M -9.87%
Market Cap ¥2.34B
P/E Ratio -
Div. Yield -
ROE 171.96%
Piotroski F-Score Weak
2/9Valuation
68 /100
Cheap P/B 1.77x
P/S 4.19x
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 48.02%
Rev. growth 38.61%
FCF growth N/A
Profitability
20 /100
Weak Net margin 216.47%
Op. margin 211.14%
FCF margin 215.17%
Quality
2 /100
Poor ROE 171.96%
ROA 30.48%
Asset turnover 0.14x
Debt
37 /100
Moderate Current ratio 1.79x
Int. coverage -22.42x
Debt/Equity 1.49x
Stability
26 /100
Unstable Rev. volatility 209.49%
EPS volatility 122.93%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o AAPG
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dajun Yang
Employees
767
Headquarters
Suzhou
Prihajajoči dogodki
31 MAR.
Earnings
Upcoming earnings report